Laura Cooper

2.4k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Laura Cooper is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Laura Cooper has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 12 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Laura Cooper's work include SARS-CoV-2 and COVID-19 Research (10 papers), SARS-CoV-2 detection and testing (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Laura Cooper is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), SARS-CoV-2 detection and testing (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Laura Cooper collaborates with scholars based in United States, China and Germany. Laura Cooper's co-authors include Lijun Rong, Hyun Lee, Hong Zhou, Huang Jin-lian, Xiaoxu Zhao, Jinghua Pan, Hui Ding, Yun-long Pan, Ruikun Du and Qinghua Cui and has published in prestigious journals such as Journal of the American Chemical Society, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Laura Cooper

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers

2019 254 citations Laura Cooper, Lijun Rong et al. profile →

Peers

Countries citing papers authored by Laura Cooper

Since Specialization

Citations

This map shows the geographic impact of Laura Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cooper more than expected).

Fields of papers citing papers by Laura Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cooper. The network helps show where Laura Cooper may publish in the future.

Co-authorship network of co-authors of Laura Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Cooper. A scholar is included among the top collaborators of Laura Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Cooper. Laura Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prototaxites fossils are structurally and chemically distinct from extinct and extant Fungi 2026 ·Science Advances ·Corentin Loron, Laura Cooper, (unknown), Seán F. Jordan, (unknown), (unknown), (unknown), Laetitia Pichevin, (unknown), (unknown), (unknown), Martin Brasier, Michael Krings, Alexander J. Hetherington	0
2	N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Laura Cooper, (unknown), (unknown), J. J. Patten, (unknown), Norton P. Peet, Robert A. Davey, Irina N. Gaisina, Lijun Rong, Terry W. Moore	0
3	Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification 2024 ·Nature Microbiology ·(unknown), Lacy M. Simons, Ramón Lorenzo-Redondo, (unknown), Laura Cooper, Tanushree Dangi, Pablo Penaloza‐MacMaster, Egon A. Ozer, Sarah E. Lutz, Lijun Rong, Judd F. Hultquist, Justin M. Richner	4
4	An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil 2024 ·Science Advances ·Irina N. Gaisina, Ping Li, Ruikun Du, (unknown), (unknown), (unknown), Balaji Manicassamy, Michael Caffrey, Terry W. Moore, Laura Cooper, Lijun Rong	10
5	Bioinspired designer DNA NanoGripper for virus sensing and potential inhibition 2024 ·Science Robotics ·Lifeng Zhou, Yanyu Xiong, Abhisek Dwivedy, Mengxi Zheng, Laura Cooper, (unknown), Tingjie Song, Wei Hong, (unknown), (unknown), (unknown), Lijun Rong, Tong Wang, Brian T. Cunningham, Xing Wang	12
6	Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition 2024 ·Journal of the American Chemical Society ·Tingjie Song, Laura Cooper, (unknown), Xiaojing Wang, Abhisek Dwivedy, Lijun Rong, Xing Wang	14
7	Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2 2023 ·Journal of Medical Virology ·(unknown), Ruikun Du, Laura Cooper, (unknown), (unknown), Ran Yan, Jiwei Zhang, Peng Zhan, Lijun Rong, Qinghua Cui	7
8	Entophysalis in the Rhynie chert (Lower Devonian, Scotland): implications for cyanobacterial evolution 2023 ·Geological Magazine ·Sean McMahon, Corentin Loron, Laura Cooper, Alexander J. Hetherington, Michael Krings	2
9	Photonic Crystal Enhanced Fluorescence with DNA-based Nano-gripper for Ultrasensitive SARS-CoV-2 Biosensing 2023 ·Yanyu Xiong, Lifeng Zhou, Laura Cooper, (unknown), Tingjie Song, Abhisek Dwivedy, Lijun Rong, Tong Wang, Xing Wang, Brian T. Cunningham	0
10	Synthesis, Optimization, and Structure–Activity Relationships of Imidazo[1,2-a]pyrimidines as Inhibitors of Group 2 Influenza A Viruses 2022 ·Journal of Medicinal Chemistry ·Saad Alqarni, Laura Cooper, (unknown), (unknown), Veeresh Kumar Sali, Andrew S. Brown, Bernard D. Santarsiero, Aleksej Krunić, Balaji Manicassamy, Norton P. Peet, Pin Zhang, Gregory R. J. Thatcher, Irina N. Gaisina, Lijun Rong, Terry W. Moore	18
11	Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants 2022 ·Nature Chemical Biology ·Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, Matthew C. Chan, Kui K. Chan, Timothy M. Fan, Keith Bailey, (unknown), Laura Cooper, Lijun Rong, (unknown), Diwakar Shukla, Erik Procko, Jalees Rehman, Asrar B. Malik	53
12	An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2 2022 ·EMBO Molecular Medicine ·Lianghui Zhang, (unknown), Laura Cooper, Kui K. Chan, (unknown), (unknown), (unknown), (unknown), Lijun Rong, Jalees Rehman, Asrar B. Malik, Erik Procko	31
13	ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 2021 ·iScience ·Naoki Iwanaga, Laura Cooper, Lijun Rong, Nicholas J. Maness, Brandon J. Beddingfield, Zhongnan Qin, Jackelyn Crabtree, Ralph A. Tripp, Haoran Yang, Robert V. Blair, Sonia Jangra, Adolfo Garcı́a-Sastre, Michael Schotsaert, Sruti Chandra, James E. Robinson, (unknown), (unknown), Xuebin Qin, Jay K. Kolls	28
14	A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery 2021 ·Antiviral Research ·Moushimi Amaya, Han Cheng, Viktoriya Borisevich, Chanakha K. Navaratnarajah, Roberto Cattaneo, Laura Cooper, Terry W. Moore, Irina N. Gaisina, Thomas W. Geisbert, Lijun Rong, Christopher C. Broder	11
15	Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry 2021 ·PLoS Pathogens ·(unknown), Rui Xiong, Laura Cooper, (unknown), Hyun Lee, Yangfeng Li, Benjamin E. Ramirez, Norton P. Peet, Michael Caffrey, Gregory R. J. Thatcher, Erica Ollmann Saphire, Han Cheng, Lijun Rong	22
16	Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro 2021 ·Antiviral Research ·Ruikun Du, Laura Cooper, (unknown), Hyun Lee, Lijun Rong, Qinghua Cui	56
17	Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity 2021 ·Journal of Medicinal Chemistry ·Zhengnan Shen, Kiira Ratia, Laura Cooper, Deyu Kong, Hyun Lee, (unknown), Yangfeng Li, Saad Alqarni, Fei Huang, Oleksii Dubrovskyi, Lijun Rong, Gregory R. J. Thatcher, Rui Xiong	125
18	N‐terminal tyrosine phosphorylation of caveolin‐2 negates anti‐proliferative effect of transforming growth factor beta in endothelial cells 2012 ·FEBS Letters ·(unknown), (unknown), Sungchan Jang, Laura Cooper, Leike Xie, (unknown), Grzegorz Sowa	7
19	Interleukin-1 Drives Cerebrovascular Inflammation via MAP Kinase-Independent Pathways 2010 ·Current Neurovascular Research ·Peter Thornton, Barry W. McColl, Laura Cooper, Nancy J. Rothwell, Stuart M. Allan	30
20	Cloning and sequencing of the cDNA encoding the human homologue of the murine immunoglobulin‐associated protein B29 1992 ·European Journal of Immunology ·Brigitte Müller, Laura Cooper, Cox Terhorst	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact